Bryn Aarflot successfully helped Intervet International in winning appeal
Bryn Aarflot has successfully helped Intervet International BV in winning appeal proceedings between Intervet (Defendant) and Pharmaq AS (Appellant).
Pharmaq decided to appeal the Norwegian Industrial Property Office’s (NIPO) decision to revoke Norwegian patent No. 333242 after opposition proceedings initiated by Intervet represented by Bryn Aarflot.
The patent concerned a vaccine against pancreas disease in fish. Intervet argued that the patent claims were not novel in view of an oral presentation. NIPO had in their patentability assessment during the opposition proceedings decided that it was unclear whether there was sufficient evidence proving that the presentation was presented and publically available prior to the date of filing.
The Board of Appeal concluded that the evidence was sufficient. They rejected the appeal and the patent remains revoked.Read more
Bryn Aarflot earns rankings in 2017 IAM Patent 1000
Bryn Aarflot has once again been recognised by Intellectual Asset Management (IAM), one of the world’s leading IP publications.Read more
Paediatric extensions of SPCs in Norway
Paediatric extensions in Norway will be implemented and available from 1 September 2017. This means that an SPC with expiry date later than 1 March 2017 is entitled to extension provided that the application for the extension is submitted according to the requirement in the regulation or in the transitional regulations.Read more
KRISTINE REKDAL ONE OF THE TOP 250
Kristine Rekdal is once again listed in Top 250 Women in IP by Managing Intellectual Property – IP Stars for 2017. Kristine heads patent at Bryn Aarflot, and needless to say, we are proud that Kristine is one of the totally four Norwegian attorneys on the list.Read more
IP FIRM OF THE YEAR 2017
Well-renowned Managing Intellectual Property (MIP) and IP Stars has awarded Bryn Aarflot the prestigious “Firm of the Year” title in the IP prosecution category for Norway as part of its Global IP Awards 2017. The award is based on extensive research and feedback from more than 10 000 clients and IP professionals world wide.Read more